Design
Review
Authors
Loading...
AT2-R stimulation may confer protection in HF; leaves open whether selective agonists merit clinical trials.
Key points are not available for this paper at this time.
Hiroaki Matsubara (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: